Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients

Clinical trial NCT05118490 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05118490
Sponsor: The Aurum Institute NPC
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

HIV Seropositivity Tuberculosis Household Contact

Start date: 2023-07-19
Primary completion: 2025-07-11
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.